BRAFTOVI

BRAFTOVI uses and dosage

BRAFTOVI (Encorafenib) is a prescription medicine used to treat patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, for adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E mutation in combination with cetuximab, and for adult patients with metastatic non-small cell lung cancer (NSCLC). Encorafenib is not indicated for patients with wild-type BRAF melanoma, CRC, or NSCLC. BRAFTOVI manufactured by Pierre Fabre pharma Ltd. in France. Encorafenib has to take orally once a day with or without food as directed by patient’s doctor.

BRAFTOVI side effects

The most common side effects of Encorafenib are: Nausea, vomiting, diarrhea, headache, tiredness, abdominal pain, joint pain or swelling, dry/itching skin, constipation, or dizziness.

Originator brand

BRAFTOVI by ARRAY BIOPHARMA INC

Made by

Pierre Fabre pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.